Compared to normal urothelial cells, AKR1B10 expression was markedly reduced, whereas FASN and RUNX2 were significantly upregulated in multiple BLCA cell lines (Supplementary Figure 6A). The gene discussed is AKR1B10; the disease is bladder transitional cell carcinoma.